Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G | 2019-07-05 | Versant Venture Capital VI, L.P. | Akero Therapeutics, Inc. | 4,104,858 | 14.7% | EDGAR |
SC 13D | 2019-07-01 | Apple Tree Partners IV, L.P. | Akero Therapeutics, Inc. | 5,415,203 | 19.4% | EDGAR |
SC 13D | 2019-06-26 | venBio Global Strategic Fund II L.P. | Akero Therapeutics, Inc. | 3,954,858 | 14.2% | EDGAR |